-
-
-
-
-
-
-
Fresenius Medical Care delivers strong operating income growth in Q1 2026 while advancing the U.S. rollout of 5008X CAREsystems at speed
-
-
-
-
-
-
-
Fresenius Medical Care (FMS) Tops Q2 EPS by 41c; offers outlook
-
-
-
-
-
-
-
Fresenius Medical Care publishes its joint Annual Report and Sustainability Statement for 2024: Building the Momentum
-
-
-
-
-
-
-
Fresenius Medical Care (FMS) Misses Q1 EPS by 4c
-
-
-
-
-
-
-
Fresenius Medical Care continues to execute on turnaround plan and raises 2023 earnings outlook due to strong operational performance in first nine months and solid business outlook for the fourth qua
-
-
-
-
-
-
-
Deutsche Bank Upgrades Fresenius Medical Care (FMS) to Buy
-
-
-
-
-
-
-
CytoSorbents Achieves Fourth Consecutive Quarter of Record CytoSorb® Sales
-
1,231,068 total articles have been posted to this entity.
Click Here to Sign-Up for StreetInsider.com Premium to View All


